It is also supported by a recent study which showed a significant decline in CD38+HLA-DR+ PPD-specific CD4+ T cells after 8 weeks of anti-TB treatment, while the CD38−HLA-DR− subset remained stable. The gene discussed is CD4; the disease is tuberculosis.